P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL)

por Kadia, T., Ravandi, F., Borthakur, G., Jabbour, E., Montalban-Bravo, G., Adewale, L., Pierce, S., Lacke, C., Brandt, M., Short, N., Jain, N., Burger, J., Ferrajoli, A., Wierda, W., Kantarjian, H.
Publicado 2022